| Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies O Abdel-Wahab, A Mullally, C Hedvat, G Garcia-Manero, J Patel, ... Blood, The Journal of the American Society of Hematology 114 (1), 144-147, 2009 | 809 | 2009 |
| A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer P Vahteristo, J Bartkova, H Eerola, K Syrjäkoski, S Ojala, O Kilpivaara, ... The American Journal of Human Genetics 71 (2), 432-438, 2002 | 556 | 2002 |
| Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis R Rampal, F Al-Shahrour, O Abdel-Wahab, JP Patel, JP Brunel, ... Blood, The Journal of the American Society of Hematology 123 (22), e123-e133, 2014 | 429 | 2014 |
| CTCF/cohesin-binding sites are frequently mutated in cancer R Katainen, K Dave, E Pitkänen, K Palin, T Kivioja, N Välimäki, AE Gylfe, ... Nature genetics 47 (7), 818-821, 2015 | 426 | 2015 |
| A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms O Kilpivaara, S Mukherjee, AM Schram, M Wadleigh, A Mullally, BL Ebert, ... Nature genetics 41 (4), 455-459, 2009 | 391 | 2009 |
| IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis A Tefferi, TL Lasho, O Abdel-Wahab, P Guglielmelli, J Patel, ... Leukemia 24 (7), 1302-1309, 2010 | 376 | 2010 |
| Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy P Koppikar, N Bhagwat, O Kilpivaara, T Manshouri, M Adli, T Hricik, F Liu, ... Nature 489 (7414), 155-159, 2012 | 360 | 2012 |
| Characterization of uterine leiomyomas by whole-genome sequencing M Mehine, E Kaasinen, N Mäkinen, R Katainen, K Kämpjärvi, E Pitkänen, ... New England Journal of Medicine 369 (1), 43-53, 2013 | 330 | 2013 |
| RAD51 135G→ C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies AC Antoniou, OM Sinilnikova, J Simard, M Léoné, M Dumont, ... The American Journal of Human Genetics 81 (6), 1186-1200, 2007 | 298 | 2007 |
| NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer R Fagerholm, B Hofstetter, J Tommiska, K Aaltonen, R Vrtel, K Syrjäkoski, ... Nature genetics 40 (7), 844-853, 2008 | 253 | 2008 |
| Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics G Jönsson, J Staaf, J Vallon-Christersson, M Ringnér, K Holm, C Hegardt, ... Breast Cancer Research 12, 1-14, 2010 | 243 | 2010 |
| Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a A Quintás-Cardama, O Abdel-Wahab, T Manshouri, O Kilpivaara, J Cortes, ... Blood, The Journal of the American Society of Hematology 122 (6), 893-901, 2013 | 238 | 2013 |
| CHEK2 variant I157T may be associated with increased breast cancer risk O Kilpivaara, P Vahteristo, J Falck, K Syrjäkoski, H Eerola, D Easton, ... International journal of cancer 111 (4), 543-547, 2004 | 183 | 2004 |
| JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science O Kilpivaara, RL Levine Leukemia 22 (10), 1813-1817, 2008 | 138 | 2008 |
| Correlation of CHEK2 protein expression and c. 1100delC mutation status with tumor characteristics among unselected breast cancer patients O Kilpivaara, J Bartkova, H Eerola, K Syrjäkoski, P Vahteristo, J Lukas, ... International journal of cancer 113 (4), 575-580, 2005 | 137 | 2005 |
| The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, ... Oncogene 27 (17), 2501-2506, 2008 | 133 | 2008 |
| Prognostic role of HuR in hereditary breast cancer M Heinonen, R Fagerholm, K Aaltonen, O Kilpivaara, K Aittomäki, ... Clinical cancer research 13 (23), 6959-6963, 2007 | 131 | 2007 |
| Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer K Kämpjärvi, N Mäkinen, O Kilpivaara, J Arola, HR Heinonen, J Böhm, ... British journal of cancer 107 (10), 1761-1765, 2012 | 124 | 2012 |
| Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer T Cajuso, UA Hänninen, J Kondelin, AE Gylfe, T Tanskanen, R Katainen, ... International journal of cancer 135 (3), 611-623, 2014 | 123 | 2014 |
| HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk VH Laitinen, T Wahlfors, L Saaristo, T Rantapero, LM Pelttari, O Kilpivaara, ... Cancer epidemiology, biomarkers & prevention 22 (3), 452-460, 2013 | 101 | 2013 |
Esa PitkänenInstitute for Molecular Medicine Finland (FIMM)Verified email at helsinki.fi
